The key point is that this is the first randomized, placebo-controlled clinical evidence that a GLP-1 receptor agonist may slow the biological processes associated with aging in humans. Michael Corley, PhD Using multiple epigenetic clocks, we saw a broad pattern of slower biological aging in participants treated with semaglutide compared with placebo, including a 9% slowing in the pace of aging measured by DunedinPACE and a significant effect on PCGrimAge, which tracks processes linked to all-cause mortality and age-related disease, the researcher detailed
Evid Based Complement Alternat Med 2013, 135314 (2013)
Some of these clients require flexible batch sizes, consistent quality, and accessible documentationall of which we provide through Certificate of Analysis (COA) availability and expert support
Moreover, inherent limitations of dairy-based products, including lactose content, cholesterol, and limited shelf life, are spurring innovation in the functional food industry
However, the evidence is mixed
.png)
